Ligand Pharmaceuticals (LGND) BidaskScore is upgraded to Bought

Ligand Pharmaceuticals, Inc.

The BidaskScore of Ligand Pharmaceuticals Incorporated LGNDLGND shows that the shares of the company are now LGNDStrongly Bought Bought by investors.

The BidaskScore of the BiotechnologyBiotechnology shows that the sector is BiotechnologyStrongly Bought Bought since May 21.

Here are the BidAskScore of other related companies in the Biotechnology sector:

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA.

Ligand Pharmaceuticals, Inc.

Launched in 2016, the BidAskClubBidaskClub allows users to follow the evolution of the US equity market. BidaskClub provides a platform to create portfolios and be informed when a company´s or sector’s BidaskScore changes. BidaskClub is provided by LuxFinAdviceLuxFinAdvice.